US Patent 11352321 Glucagon antagonists
Patent 11352321 was granted and assigned to METABASIS THERAPEUTICS, INC. on June, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11352321 Glucagon antagonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.